Published in J Biol Chem on December 27, 2000
Stabilities and conformations of Alzheimer's beta -amyloid peptide oligomers (Abeta 16-22, Abeta 16-35, and Abeta 10-35): Sequence effects. Proc Natl Acad Sci U S A (2002) 3.06
Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci U S A (2003) 2.71
Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. Proc Natl Acad Sci U S A (2002) 2.23
Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A (2004) 1.83
Linking folding with aggregation in Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci U S A (2007) 1.42
Prediction of "hot spots" of aggregation in disease-linked polypeptides. BMC Struct Biol (2005) 1.34
Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. Proc Natl Acad Sci U S A (2005) 1.31
Detecting hidden sequence propensity for amyloid fibril formation. Protein Sci (2004) 1.25
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Brain (2006) 1.25
The role of protein stability, solubility, and net charge in amyloid fibril formation. Protein Sci (2003) 1.20
Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid. Biochem J (2003) 1.20
Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli. Protein Sci (2005) 1.18
Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis. Proc Natl Acad Sci U S A (2009) 1.15
Alpha-helix targeting reduces amyloid-beta peptide toxicity. Proc Natl Acad Sci U S A (2009) 1.11
The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? Alzheimers Res Ther (2010) 1.09
Structural defects and the diagnosis of amyloidogenic propensity. Proc Natl Acad Sci U S A (2003) 1.08
A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins. PLoS One (2013) 1.08
Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase. Protein Sci (2006) 1.07
High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. Proc Natl Acad Sci U S A (2012) 1.06
Properties of the thioredoxin fold superfamily are modulated by a single amino acid residue. J Biol Chem (2009) 1.05
Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases. Expert Rev Mol Med (2010) 1.04
Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci (2004) 1.03
BRICHOS - a superfamily of multidomain proteins with diverse functions. BMC Res Notes (2009) 1.02
Defined DNA sequences promote the assembly of a bacterial protein into distinct amyloid nanostructures. Proc Natl Acad Sci U S A (2007) 1.01
Sequence periodicity and secondary structure propensity in model proteins. Protein Sci (2010) 1.00
Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer. Biochemistry (2006) 0.98
AMYPdb: a database dedicated to amyloid precursor proteins. BMC Bioinformatics (2008) 0.97
Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptide. ACS Chem Neurosci (2012) 0.97
Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments. Biophys J (2002) 0.96
Stabilization of discordant helices in amyloid fibril-forming proteins. Protein Sci (2004) 0.95
Deacylated pulmonary surfactant protein SP-C transforms from alpha-helical to amyloid fibril structure via a pH-dependent mechanism: an infrared structural investigation. Biophys J (2003) 0.91
Amyloidogenic sequences in native protein structures. Protein Sci (2010) 0.91
Unfolding of the amyloid β-peptide central helix: mechanistic insights from molecular dynamics simulations. PLoS One (2011) 0.91
Checking the pH-induced conformational transition of prion protein by molecular dynamics simulations: effect of protonation of histidine residues. Biophys J (2004) 0.90
Comparative computational analysis of prion proteins reveals two fragments with unusual structural properties and a pattern of increase in hydrophobicity associated with disease-promoting mutations. Protein Sci (2004) 0.90
Structural instability of the prion protein upon M205S/R mutations revealed by molecular dynamics simulations. Biophys J (2006) 0.88
Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease. PLoS One (2007) 0.87
The Brichos domain of prosurfactant protein C can hold and fold a transmembrane segment. Protein Sci (2009) 0.86
Specific Chaperones and Regulatory Domains in Control of Amyloid Formation. J Biol Chem (2015) 0.86
A structural overview of the vertebrate prion proteins. Prion (2007) 0.84
Current and future treatment of amyloid diseases. J Intern Med (2016) 0.83
Exploring the sequence-structure relationship for amyloid peptides. Biochem J (2013) 0.82
Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue. J Biol Chem (2010) 0.82
Protein folding and aggregation into amyloid: the interference by natural phenolic compounds. Int J Mol Sci (2013) 0.81
The detection of surfactant proteins A, B, C and D in the human brain and their regulation in cerebral infarction, autoimmune conditions and infections of the CNS. PLoS One (2013) 0.81
Effects of ligands on unfolding of the amyloid β-peptide central helix: mechanistic insights from molecular dynamics simulations. PLoS One (2012) 0.81
4-Phenylbutyric acid treatment rescues trafficking and processing of a mutant surfactant protein-C. Am J Respir Cell Mol Biol (2012) 0.81
The mechanism of fibril formation of a non-inhibitory serpin ovalbumin revealed by the identification of amyloidogenic core regions. J Biol Chem (2010) 0.80
Effects of oligomerization and secondary structure on the surface behavior of pulmonary surfactant proteins SP-B and SP-C. Biophys J (2003) 0.80
Fibril-forming motifs are essential and sufficient for the fibrillization of human Tau. PLoS One (2012) 0.80
Biomimicry of surfactant protein C. Acc Chem Res (2008) 0.80
Prediction of Peptide and Protein Propensity for Amyloid Formation. PLoS One (2015) 0.80
Discordant and chameleon sequences: their distribution and implications for amyloidogenicity. Protein Sci (2011) 0.79
Effect of alanine replacement of l17 and f19 on the aggregation and neurotoxicity of arctic-type aβ40. PLoS One (2013) 0.79
Molecular dynamics studies of alpha-helix stability in fibril-forming peptides. J Comput Aided Mol Des (2007) 0.78
Helices 2 and 3 are the initiation sites in the PrP(C) → PrP(SC) transition. Biochemistry (2012) 0.78
The N-terminal helix controls the transition between the soluble and amyloid states of an FF domain. PLoS One (2013) 0.77
Effects of dithiothreitol on the amyloid fibrillogenesis of hen egg-white lysozyme. Eur Biophys J (2010) 0.77
New insight into serpin polymerization and aggregation. Prion (2009) 0.76
Association between foldability and aggregation propensity in small disulfide-rich proteins. Antioxid Redox Signal (2014) 0.76
Self-Assembly and Anti-Amyloid Cytotoxicity Activity of Amyloid beta Peptide Derivatives. Sci Rep (2017) 0.75
A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments. Yonsei Med J (2017) 0.75
Transthyretin and BRICHOS: The Paradox of Amyloidogenic Proteins with Anti-Amyloidogenic Activity for Aβ in the Central Nervous System. Front Neurosci (2017) 0.75
Folding and Intramembraneous BRICHOS Binding of the Prosurfactant Protein C Transmembrane Segment. J Biol Chem (2015) 0.75
L17A/F19A Substitutions Augment the α-Helicity of β-Amyloid Peptide Discordant Segment. PLoS One (2016) 0.75
Aggregation of Chameleon Peptides: Implications of α-Helicity in Fibril Formation. J Phys Chem B (2016) 0.75
Sequence determinants of cytosolic N-terminal protein processing. Eur J Biochem (1986) 5.59
Short-chain dehydrogenases/reductases (SDR). Biochemistry (1995) 5.34
Modulation of virulence factor expression by pathogen target cell contact. Science (1996) 3.99
Quantum annealing with manufactured spins. Nature (2011) 3.81
Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol (1999) 3.28
Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques (1991) 3.13
Medium- and short-chain dehydrogenase/reductase gene and protein families : the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cell Mol Life Sci (2008) 3.07
Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem (1996) 2.93
Microtubules and the organization of the Golgi complex. Exp Cell Res (1985) 2.69
The direction of membrane lipid flow in locomoting polymorphonuclear leukocytes. Science (1990) 2.58
Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J (1998) 2.49
Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol (2001) 2.36
Morbidity of 10 110 hysterectomies by type of approach. Hum Reprod (2001) 2.28
The 21-residue surfactant peptide (LysLeu4)4Lys(KL4) is a transmembrane alpha-helix with a mixed nonpolar/polar surface. FEBS Lett (1996) 2.19
Characteristics of alcohol/polyol dehydrogenases. The zinc-containing long-chain alcohol dehydrogenases. Eur J Biochem (1987) 2.17
A molecular model of Alzheimer amyloid beta-peptide fibril formation. J Biol Chem (1999) 2.12
Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A (2001) 2.11
Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J (2003) 1.97
Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med (2000) 1.96
Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol (1999) 1.94
Structures of N-terminally acetylated proteins. Eur J Biochem (1985) 1.92
Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem (1993) 1.81
Controlled polytypic and twin-plane superlattices in iii-v nanowires. Nat Nanotechnol (2008) 1.79
Influence of colchicine and vinblastine on the golgi complex and matrix deposition in chondrocyte aggregates. An ultrastructural study. Exp Cell Res (1975) 1.75
Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci U S A (1985) 1.74
SDR and MDR: completed genome sequences show these protein families to be large, of old origin, and of complex nature. FEBS Lett (1999) 1.73
Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol (1988) 1.73
Common structural features of MAPEG -- a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci (1999) 1.70
Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. J Chromatogr (1992) 1.67
Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol (1983) 1.67
Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64
Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the gene for the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF-like protein. Proc Natl Acad Sci U S A (1986) 1.62
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg (2000) 1.59
Family infections by reo-like virus. Comparison of antibody titres by complement fixation and immunoelectroosmophoresis. Scand J Infect Dis (1977) 1.57
Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J Biol Chem (1998) 1.57
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron (1995) 1.56
Health effects of working in pulp and paper mills: malignant diseases. Am J Ind Med (1996) 1.56
Cadmium exposure and end-stage renal disease. Am J Kidney Dis (2001) 1.55
Consensus predictions of membrane protein topology. FEBS Lett (2000) 1.55
Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol (1994) 1.54
Proteoglycans of hyaline cartilage: Electron-microscopic studies on isolated molecules. Biochem J (1975) 1.54
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
The imprint of the extragalactic background light in the gamma-ray spectra of blazars. Science (2012) 1.53
Studies with ubiquinone-depleted submitochondrial particles. Essentiality of ubiquinone for the interaction of succinate dehydrogenase, NADH dehydrogenase, and cytochrome b. Eur J Biochem (1969) 1.53
Low-level cadmium exposure and osteoporosis. J Bone Miner Res (2000) 1.53
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg (2000) 1.53
Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods (1995) 1.51
The effect of local anaesthetics on the central circulation and respiration in man and dog. Acta Anaesthesiol Scand (1968) 1.50
Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr (1989) 1.46
Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci U S A (1990) 1.45
Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab (2000) 1.44
Controlling amyloid beta-peptide fibril formation with protease-stable ligands. J Biol Chem (1997) 1.43
Hunger behaviour contributes to early nutritional homeostasis. Acta Paediatr (1998) 1.42
The pattern of blood lipids, glycerol and ketone bodies during the neonatal period, infancy and childhood. Acta Paediatr Scand (1966) 1.42
Magnetic resonance imaging and aneurysm clips. Magnetic properties and image artifacts. J Neurosurg (1989) 1.41
Pulmonary surfactant from healthy Belgian White and Blue and Holstein Friesian calves: biochemical and biophysical comparison. Vet J (2003) 1.39
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer (1992) 1.39
A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res (2000) 1.38
Electron microscopic demonstration of proteoglycans in guinea pig epiphyseal cartilage. J Ultrastruct Res (1973) 1.38
Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. Br J Clin Pharmacol (1983) 1.35
Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation (1998) 1.34
Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem (1988) 1.34
Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia (1990) 1.34
Studies with ubiquinone-depleted submitochondrial particles. Effects of extraction and reincorporation of ubiquinone on the kinetics of succinate dehydrogenase. Eur J Biochem (1970) 1.33
Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. Differentiation (1983) 1.33
TMAP: a new email and WWW service for membrane-protein structural predictions. Trends Biochem Sci (1995) 1.32
Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Br Med J (Clin Res Ed) (1984) 1.31
Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation (2001) 1.31
Chronic lymphatic leukaemia and engine exhausts, fresh wood, and DDT: a case-referent study. Br J Ind Med (1988) 1.30
Cerebral blood flow and exchange of oxygen, glucose, ketone bodies, lactate, pyruvate and amino acids in infants. Acta Paediatr Scand (1976) 1.29
Secondary structure and orientation of the surfactant protein SP-B in a lipid environment. A Fourier transform infrared spectroscopy study. Biochemistry (1992) 1.28
A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance. Mol Microbiol (2000) 1.28
Biosynthesis of bile acids in man. Hydroxylation of the C27-steroid side chain. J Clin Invest (1975) 1.27
Amyloid beta-peptide polymerization studied using fluorescence correlation spectroscopy. Chem Biol (1999) 1.26
Structure and orientation of the surfactant-associated protein C in a lipid bilayer. Eur J Biochem (1992) 1.24
Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study. Kidney Int (1992) 1.24
An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett (1995) 1.24
Cysteine-scanning mutagenesis of putative helix VII in the lactose permease of Escherichia coli. Biochemistry (1994) 1.24
Catecholamine surge and metabolic adaptation in the newborn after vaginal delivery and caesarean section. Acta Paediatr Scand (1984) 1.23
Outcome of pregnancies complicated by type 1 insulin-dependent diabetes in Sweden: acute pregnancy complications, neonatal mortality and morbidity. Am J Perinatol (1993) 1.22
Retention of the transforming growth factor-beta 1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J Biol Chem (1992) 1.21
Active site directed mutagenesis of 3 beta/17 beta-hydroxysteroid dehydrogenase establishes differential effects on short-chain dehydrogenase/reductase reactions. Biochemistry (1997) 1.20
Adenosine mechanisms in the regulation of breathing in the rat. Eur J Pharmacol (1984) 1.20
Influence of colchicine on the synthesis and secretion of proteoglycans and collagen by fetal guinea pig chondrocytes. Exp Cell Res (1976) 1.19
Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology (1998) 1.19
Carotid artery diameter correlates with risk factors for cardiovascular disease in a population of 55-year-old subjects. Stroke (1999) 1.18
Low-molecular-mass surfactant protein type 1. The primary structure of a hydrophobic 8-kDa polypeptide with eight half-cystine residues. Eur J Biochem (1988) 1.17
Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner. J Cell Biol (1988) 1.17
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils. J Biol Chem (1994) 1.17
Cellular UDP-glucose deficiency caused by a single point mutation in the UDP-glucose pyrophosphorylase gene. J Biol Chem (1997) 1.17
Neonatal hypoglycemia: a discussion. J Pediatr (1971) 1.16
TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur J Clin Invest (2008) 1.15
Integrin alpha(2)beta(1) (VLA-2) is a principal receptor used by neutrophils for locomotion in extravascular tissue. Blood (2000) 1.15
Blood cadmium as an indicator of dose in a long-term follow-up of workers previously exposed to cadmium. Scand J Work Environ Health (1997) 1.14
Fluorescence imaging and point measurements of tissue: applications to the demarcation of malignant tumors and atherosclerotic lesions from normal tissue. Photochem Photobiol (1991) 1.14
Protein structure prediction: recognition of primary, secondary, and tertiary structural features from amino acid sequence. Crit Rev Biochem Mol Biol (1995) 1.14
Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. Differentiation (1987) 1.14
Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. J Pharm Pharmacol (1982) 1.14